Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04343248
Recruitment Status : Active, not recruiting
First Posted : April 13, 2020
Last Update Posted : April 1, 2021
Sponsor:
Information provided by (Responsible Party):
Romark Laboratories L.C.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : June 30, 2021